Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in Infants
2023; American Medical Association; Volume: 178; Issue: 2 Linguagem: Inglês
10.1001/jamapediatrics.2023.5639
ISSN2168-6211
AutoresLeila C. Sahni, Samantha M. Olson, Natasha Halasa, Laura S Stewart, Marian G. Michaels, John V. Williams, Janet A. Englund, Eileen J. Klein, Mary Allen Staat, Elizabeth P. Schlaudecker, Rangaraj Selvarangan, Jennifer E. Schuster, Geoffrey A. Weinberg, Peter G. Szilagyi, Julie A. Boom, Manish M. Patel, Flor M. Muñoz, Monica McNeal, Chelsea Rohlfs, Miranda Howard, Vasanthi Avadhanula, Pedro A. Piedra, Christopher J. Harrison, Mary E. Moffat, Gina Weddle, Robert W. Hickey, Judith M. Martin, Karine Lacombe, Hanna Schlaack, Bonnie Strelitz,
Tópico(s)Respiratory viral infections research
ResumoInfluenza virus infection during pregnancy is associated with severe maternal disease and may be associated with adverse birth outcomes. Inactivated influenza vaccine during pregnancy is safe and effective and can protect young infants, but recent evidence, particularly after the 2009 novel influenza A (H1N1) pandemic, is limited.
Referência(s)